AbstractDiseases of protein aggregationWang et al.: Biotechnol. J. 2008, 3, 165–192Protein aggregation is a ubiquitous phenomenon frequently encountered in biochemical research and the biopharmaceutical industry. It is generally regarded to be associated with partially folded intermediate species that are susceptible to self‐association due to the exposure of a hydrophobic core. Evidence supports the concept that the formation of aggregates in vitro is a generic property of proteins. In human etiology, more than 20 different devastating human diseases have been reported to be associated with protein aggregation in vivo. In this review, researchers from Taiwan and Japan summarize the properties, characteristics and causes of protein aggregates. They briefly discuss two examples of protein aggregation diseases, Alzheimer's disease and cataract. Investigation into drug penetration, efficacy, and side effects will certainly aid in developing successful pharmacological agents for these diseases.Protein recovery from inclusion bodiesDoglia et al.: Biotechnol. J. 2008, 3, 193–201As bacterially overexpressed polypeptides mostly undergo aggregation in inclusion bodies, they have to be recovered by solubilization and refolding procedures. However, recent studies have shown that proteins embedded in inclusion bodies may retain residual structure and biological function and question the former axiom that solubility and activity are necessarily coupled. This allows for a switch in the goals from obtaining soluble products to controlling the conformational quality of aggregated proteins. Central to this approach is the availability of analytical methods to monitor protein structure within inclusion bodies. Researchers from Italy here describe the use of Fourier transform infrared spectroscopy for the structural analysis of inclusion bodies both purified from cells and in vivo. They show kinetics of aggregation and structure of aggregates as a function of expression levels, temperature and co‐expression of chaperones.LC‐MS for protein biosysnthesis analysisJani et al.: Biotechnol. J. 2008, 3, 202–208The optimization of the biosynthetic pathways is highly attractive for the large‐scale preparation of macrotetrolides, because overall yields in the chemical synthesis of compounds like nonactin have been very low. A key success factor determining the outcome of such optimizations is the adequate process analysis for the envisioned product. The analytical methods for process control so far involved spectrophotometric and chromatographic measurements. As shown by the group of Roland Wohlgemuth (Sigma‐Aldrich, Switzerland), LC‐MS offers a modern approach to obtain more detailed data than the spectrophotometric and chromatographic measurements used in the past. LC‐MS combines the advantages of a chromatographic separation with mass detection by MS. Low detection limits and qualified analysis of molecular structures brought this application a new and growing popularity in the field of biotechnology. In this work, a fast and versatile analytical LC‐MS method has been set up. It is used for the in‐process analysis of macrotetrolides during fermentation and allows rapid large‐scale bioprocess development.
Read full abstract